Temporal Changes in Characteristics, Treatment and Outcomes of Heart Failure Patients Undergoing Percutaneous Coronary Intervention Findings from Melbourne Interventional Group Registry

Ken Lee Chin, Mark Alan Tacey, Christopher M. Reid, Andrew Maxwell Tonkin, Ingrid Kate Hopper, Angela Brennan, Nick Andrianopoulos, Stephen Duffy, David Clark, Andrew E Ajani, Danny Yearn Hian Liew, for the Melbourne Interventional Group (MIG)

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: Limited data exist on whether outcomes of patients with heart failure (HF) undergoing percutaneous coronary intervention (PCI) have improved over time. The purpose of this study was to assess temporal trends in patient characteristics, treatment and outcomes of patients with HF undergoing PCI. Methods: Using data from the Melbourne Interventional Group (MIG), we evaluated temporal trends of procedure volume, major adverse cardiac events (MACE; a composite of all-cause mortality, myocardial infarction and target vessel revascularisation) and rates of cardiovascular readmission, all-cause death and cardiovascular death in consecutive patients with HF undergoing PCI. Change over time was assessed by Box-Jenkins autoregressive integrated moving average (ARIMA) models. Results: Data from 1604 patients were analysed. In our cohort, there were no significant changes in the number of procedures performed annually and patient characteristics between January 2005 and December 2014. Optimal use of HF therapy has improved over the study period. Planned clopidogrel therapy of more than 12 months increased in tandem with increasing use of drug-eluting stents (DES). Procedural success was high (≥90%). However, the rates of MACE, cardiovascular readmission, all-cause death and cardiovascular death remained unchanged throughout the study period. Conclusions: Clinical outcomes in HF patients undergoing PCI have remained unchanged despite improvement in medical technology and contemporary therapeutic measures.

Original languageEnglish
Number of pages9
JournalHeart Lung and Circulation
DOIs
Publication statusAccepted/In press - 8 Jun 2018

Keywords

  • Forecasting
  • Heart failure
  • Percutaneous coronary intervention
  • Trends

Cite this

@article{42ce18d50016448b97b7198a2ee31fea,
title = "Temporal Changes in Characteristics, Treatment and Outcomes of Heart Failure Patients Undergoing Percutaneous Coronary Intervention Findings from Melbourne Interventional Group Registry",
abstract = "Background: Limited data exist on whether outcomes of patients with heart failure (HF) undergoing percutaneous coronary intervention (PCI) have improved over time. The purpose of this study was to assess temporal trends in patient characteristics, treatment and outcomes of patients with HF undergoing PCI. Methods: Using data from the Melbourne Interventional Group (MIG), we evaluated temporal trends of procedure volume, major adverse cardiac events (MACE; a composite of all-cause mortality, myocardial infarction and target vessel revascularisation) and rates of cardiovascular readmission, all-cause death and cardiovascular death in consecutive patients with HF undergoing PCI. Change over time was assessed by Box-Jenkins autoregressive integrated moving average (ARIMA) models. Results: Data from 1604 patients were analysed. In our cohort, there were no significant changes in the number of procedures performed annually and patient characteristics between January 2005 and December 2014. Optimal use of HF therapy has improved over the study period. Planned clopidogrel therapy of more than 12 months increased in tandem with increasing use of drug-eluting stents (DES). Procedural success was high (≥90{\%}). However, the rates of MACE, cardiovascular readmission, all-cause death and cardiovascular death remained unchanged throughout the study period. Conclusions: Clinical outcomes in HF patients undergoing PCI have remained unchanged despite improvement in medical technology and contemporary therapeutic measures.",
keywords = "Forecasting, Heart failure, Percutaneous coronary intervention, Trends",
author = "Chin, {Ken Lee} and Tacey, {Mark Alan} and Reid, {Christopher M.} and Tonkin, {Andrew Maxwell} and Hopper, {Ingrid Kate} and Angela Brennan and Nick Andrianopoulos and Stephen Duffy and David Clark and Ajani, {Andrew E} and Liew, {Danny Yearn Hian} and {for the Melbourne Interventional Group (MIG)}",
year = "2018",
month = "6",
day = "8",
doi = "10.1016/j.hlc.2018.03.030",
language = "English",
journal = "Heart Lung and Circulation",
issn = "1443-9506",
publisher = "Elsevier",

}

TY - JOUR

T1 - Temporal Changes in Characteristics, Treatment and Outcomes of Heart Failure Patients Undergoing Percutaneous Coronary Intervention Findings from Melbourne Interventional Group Registry

AU - Chin, Ken Lee

AU - Tacey, Mark Alan

AU - Reid, Christopher M.

AU - Tonkin, Andrew Maxwell

AU - Hopper, Ingrid Kate

AU - Brennan, Angela

AU - Andrianopoulos, Nick

AU - Duffy, Stephen

AU - Clark, David

AU - Ajani, Andrew E

AU - Liew, Danny Yearn Hian

AU - for the Melbourne Interventional Group (MIG)

PY - 2018/6/8

Y1 - 2018/6/8

N2 - Background: Limited data exist on whether outcomes of patients with heart failure (HF) undergoing percutaneous coronary intervention (PCI) have improved over time. The purpose of this study was to assess temporal trends in patient characteristics, treatment and outcomes of patients with HF undergoing PCI. Methods: Using data from the Melbourne Interventional Group (MIG), we evaluated temporal trends of procedure volume, major adverse cardiac events (MACE; a composite of all-cause mortality, myocardial infarction and target vessel revascularisation) and rates of cardiovascular readmission, all-cause death and cardiovascular death in consecutive patients with HF undergoing PCI. Change over time was assessed by Box-Jenkins autoregressive integrated moving average (ARIMA) models. Results: Data from 1604 patients were analysed. In our cohort, there were no significant changes in the number of procedures performed annually and patient characteristics between January 2005 and December 2014. Optimal use of HF therapy has improved over the study period. Planned clopidogrel therapy of more than 12 months increased in tandem with increasing use of drug-eluting stents (DES). Procedural success was high (≥90%). However, the rates of MACE, cardiovascular readmission, all-cause death and cardiovascular death remained unchanged throughout the study period. Conclusions: Clinical outcomes in HF patients undergoing PCI have remained unchanged despite improvement in medical technology and contemporary therapeutic measures.

AB - Background: Limited data exist on whether outcomes of patients with heart failure (HF) undergoing percutaneous coronary intervention (PCI) have improved over time. The purpose of this study was to assess temporal trends in patient characteristics, treatment and outcomes of patients with HF undergoing PCI. Methods: Using data from the Melbourne Interventional Group (MIG), we evaluated temporal trends of procedure volume, major adverse cardiac events (MACE; a composite of all-cause mortality, myocardial infarction and target vessel revascularisation) and rates of cardiovascular readmission, all-cause death and cardiovascular death in consecutive patients with HF undergoing PCI. Change over time was assessed by Box-Jenkins autoregressive integrated moving average (ARIMA) models. Results: Data from 1604 patients were analysed. In our cohort, there were no significant changes in the number of procedures performed annually and patient characteristics between January 2005 and December 2014. Optimal use of HF therapy has improved over the study period. Planned clopidogrel therapy of more than 12 months increased in tandem with increasing use of drug-eluting stents (DES). Procedural success was high (≥90%). However, the rates of MACE, cardiovascular readmission, all-cause death and cardiovascular death remained unchanged throughout the study period. Conclusions: Clinical outcomes in HF patients undergoing PCI have remained unchanged despite improvement in medical technology and contemporary therapeutic measures.

KW - Forecasting

KW - Heart failure

KW - Percutaneous coronary intervention

KW - Trends

UR - http://www.scopus.com/inward/record.url?scp=85049005799&partnerID=8YFLogxK

U2 - 10.1016/j.hlc.2018.03.030

DO - 10.1016/j.hlc.2018.03.030

M3 - Article

JO - Heart Lung and Circulation

JF - Heart Lung and Circulation

SN - 1443-9506

ER -